A Patient Died After His Insurance Denied His Medication. West Virginia Responded With Legislation.
A Patient Died After His Insurance Denied His Medication. West Virginia Responded With Legislation.
5 minute read
KFF Health News reported in April 2026 on West Virginia's legislative response to a prior authorization death: a patient died after his insurance company repeatedly denied coverage for his medication, and the case became a catalyst for the state to strengthen its prior authorization reform laws.¹
This is not an isolated incident. The accumulation of documented cases in which delayed or denied access to specialty medications has led to serious harm is part of why the prior authorization reform movement has gained so much legislative momentum in the past two years. Twenty-three states have enacted new or strengthened prior authorization protections as of 2026, and cases like the one in West Virginia explain why those reforms are happening.
Understanding this story, what went wrong, what the law is changing, and what rights you have right now, is one of the more important things you can do if you take a specialty drug.
Why Prior Authorization Denials Can Become Life-Threatening
For some medications, there is no clinical substitute. Specialty biologics for conditions like multiple sclerosis, inflammatory bowel disease, pulmonary arterial hypertension, hereditary angioedema, and hemophilia are not interchangeable with cheaper alternatives, and delays in access are not merely inconvenient. They can mean disease progression, hospitalization, or worse.
The prior authorization system was designed as a cost and quality management tool. In its original form, it was applied narrowly to high-cost or high-risk treatments to verify that simpler alternatives had been considered. Over time, it expanded to encompass a much broader range of treatments, including many where the clinical evidence for prior authorization requirements is weak and the primary effect is to create barriers that a proportion of patients never overcome.
A 2023 AMA survey found that 34 percent of physicians had experienced a patient suffering a serious adverse event because of a prior authorization delay.² When a prior authorization process takes days or weeks and the medication being held up is one that prevents organ damage, prevents relapse, or maintains a condition that destabilizes rapidly without treatment, that delay carries real clinical risk.
West Virginia's response to the patient death reported by KFF Health News reflects a pattern that has repeated across multiple states: a specific, documented, human case makes the systemic problem impossible to ignore, and legislation follows.
What West Virginia's Reform Does
West Virginia was already among the states with an active gold card program before the 2025 amendments, which extended gold card privileges to group practices, increased look-back periods for evaluating physician approval rates, and refined coverage categories.³
The broader set of changes that followed the patient death case addressed two of the most common systemic failures in prior authorization: appeals that go nowhere, and urgent situations where the standard review timeline is clinically dangerous.
West Virginia strengthened requirements around expedited review, ensuring that cases where the standard timeline would seriously jeopardize health or life are evaluated within the legally mandated urgent timeframe. It also expanded requirements around the specificity of denial language, a provision that matters enormously in practice.
One of the most frequent complaints from patients and physicians about the prior authorization system is that denial letters say very little. "Not medically necessary" is technically a denial reason, but it does not tell your physician what clinical standard was applied, what evidence they failed to provide, or what would be needed to succeed on appeal. States that require specific denial language are addressing this directly: the insurer must tell you which coverage criteria were not met and what information would be needed for reconsideration.
What You Can Ask For Right Now
Regardless of what state you live in, there are several things you have the right to ask your insurer when your prior authorization is denied or delayed.
Ask for the specific clinical coverage criteria that apply to your medication and condition. You are entitled to know what standard your prior authorization request was evaluated against. If the denial says "not medically necessary," you can follow up in writing asking for the specific clinical criteria that were applied and a citation of the coverage policy.
Ask for the denial letter in writing. Verbal denials are not acceptable under most state and federal requirements. You are entitled to a written denial with a reason, and for Medicare Advantage plans, the reason must be clinically specific.
Ask whether your state has expedited appeal provisions. If waiting for a standard appeal timeline would seriously jeopardize your health, you may qualify for an expedited appeal, which is required to be processed within 72 hours under federal Medicare Advantage rules and within similarly short windows under many state commercial plan regulations.
Ask your physician about peer-to-peer review. A peer-to-peer review is a direct conversation between your prescribing physician and the insurer's medical reviewer. Research consistently shows that this step resolves a significant proportion of prior authorization denials, because it allows your physician to directly address the clinical concerns the reviewer has, rather than relying on documentation alone.
File a complaint if timelines are violated. If your insurer exceeds the required timeline for a prior authorization decision, that is a reportable violation. File a complaint with your state insurance commissioner's office and, for Medicare Advantage plans, with CMS. These complaints create a record that regulators use to evaluate insurer compliance.
The Broader Pattern
West Virginia is not the only state where a specific, tragic case has accelerated legislative action. The same pattern has appeared in California, New York, Texas, and Florida over the past several years. The legislative reforms that have resulted are uneven, because the political and insurance market landscape varies by state. But the momentum toward reform is clear, and the documented cases of harm have been a significant driver.
What is still missing, in most states and at the federal level for commercial plans, is an enforcement mechanism with real consequences. Regulatory complaints can trigger audits. They can result in fines. But they rarely result in outcomes that directly compensate the individual patient who was harmed. The advocacy community has been pushing for stronger enforcement tools, and that conversation is ongoing in several state legislatures.
In the meantime, the most powerful thing you can do if you are in a prior authorization situation that feels urgent is to act quickly, document everything, and use every formal channel available to you, from peer-to-peer requests to formal appeals to regulatory complaints.
Frequently Asked Questions
What is the difference between a standard prior authorization appeal and an expedited appeal?
A standard appeal follows your plan's normal internal review timeline, which varies by state and plan but is typically 30 to 60 days for internal review and 45 to 60 days for external review. An expedited appeal is triggered when your physician certifies that waiting for the standard timeline would seriously jeopardize your health, your life, or your ability to regain maximum function. For Medicare Advantage plans, expedited appeals must be decided within 72 hours.
My prior authorization has been pending for two weeks with no decision. What should I do?
Call your insurer and ask for the status. Get the name of the representative and document the call. Ask specifically whether any additional documentation has been requested and has not yet been received. If you are in a state with mandatory prior authorization decision timelines and the timeline has been exceeded, ask your physician's office to file a complaint with your state insurance commissioner on your behalf and simultaneously file one yourself.
Can a prior authorization delay or denial be a basis for legal action?
Potentially, in some circumstances. Several states have "bad faith" insurance statutes that allow policyholders to pursue legal action when an insurer unreasonably denies or delays a claim. The specifics vary significantly by state, and these cases are complex. If you believe you have experienced a serious harm as a result of an insurer's denial or delay, consulting a patient advocate or an attorney who handles insurance disputes may be appropriate.
Ellen was built for moments like this one. If you have received a denial for a specialty medication, or if your authorization has been stalled without explanation, Ellen can help you understand what happened and what to do next. Start here.
Sources: